Nicolai V. Bovin

Solution structure of two xenoantigens: alpha Gal-LacNAc and alpha Gal-Lewis X.

Assembly of p-selectin ligands on a polymeric template.

Primary colorectal carcinomas and their intrapulmonary metastases: clinical, glyco-, immuno- and lectin histochemical, nuclear and syntactic structure analysis with emphasis on correlation with period of occurrence of metastases and survival.

Constitutively unmasked CD22 on B cells of ST6Gal I knockout mice: novel sialoside probe for murine CD22.

Glucocorticoid-induced differential expression of the sialylated and nonsialylated Lewis(a) epitopes and respective binding sites in human nasal polyps maintained under ex vivo tissue culture conditions.

Analysis of binding of mannosides in relation to Langerin (CD207) in Langerhans cells of normal and transformed epithelia.

Polyglycine II nanosheets: supramolecular antivirals?

Neoglycoconjugates: trade and art.

P-selectin blocking potency of multimeric tyrosine sulfates in vitro and in vivo.

Cyclometalated ruthenium(II) complexes as efficient redox mediators in peroxidase catalysis.

Binding sites for Lewis antigens are expressed by human colon cancer cells and negatively affect their migration.

Dextran sulfate acts as an endothelial cell protectant and inhibits human complement and natural killer cell-mediated cytotoxicity against porcine cells.

Endothelial cell protection by dextran sulfate: a novel strategy to prevent acute vascular rejection in xenotransplantation.

Up-regulation of galectin-3 and its ligands by Trypanosoma cruzi infection with modulation of adhesion and migration of murine dendritic cells.

Multimeric tyrosine sulfate acts as an endothelial cell protectant and prevents complement activation in xenotransplantation models.

Membrane-associated heparan sulfate proteoglycans are involved in the recognition of cellular targets by NKp30 and NKp46.

Anti-alpha-galactosyl antibodies recognizing epitopes terminating with alpha1,4-linked galactose: human natural and mouse monoclonal anti-NOR and anti-P1 antibodies.

Glycan array screening reveals a candidate ligand for Siglec-8.

Multimeric glycotherapeutics: new paradigm.

High molecular weight neoglycoconjugates for solid phase assays.

Receptor-binding properties of swine influenza viruses isolated and propagated in MDCK cells.

Locally targeted cytoprotection with dextran sulfate attenuates experimental porcine myocardial ischaemia/reperfusion injury.

Influence of the combined ABO, FUT2, and FUT3 polymorphism on susceptibility to Norwalk virus attachment.

Endothelial cell protection and complement inhibition in xenotransplantation: a novel in vitro model using whole blood.

alpha2,3/alpha2,6-Sialylation of N-glycans: non-synonymous signals with marked developmental regulation in bovine reproductive tracts.

Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants.

Flow-enhanced adhesion regulated by a selectin interdomain hinge.

Synthetic blood group antigens for anti-A removal device and their interaction with monoclonal anti-A IgM.

Monoclonal anti-A antibody removal by synthetic A antigen immobilized on specific antibody filters.

The amino acids involved in the distinct carbohydrate specificities between macrophage galactose-type C-type lectins 1 and 2 (CD301a and b) of mice.

Replacing a lectin domain residue in L-selectin enhances binding to P-selectin glycoprotein ligand-1 but not to 6-sulfo-sialyl Lewis x.

Galectin-loaded cells as a platform for the profiling of lectin specificity by fluorescent neoglycoconjugates: a case study on galectins-1 and -3 and the impact of assay setting.

Human-like receptor specificity does not affect the neuraminidase-inhibitor susceptibility of H5N1 influenza viruses.

6-sulfo sialyl Lewis X is the common receptor determinant recognized by H5, H6, H7 and H9 influenza viruses of terrestrial poultry.

Experimental evolution of human influenza virus H3 hemagglutinin in the mouse lung identifies adaptive regions in HA1 and HA2.

Eosinophil-selective binding and proapoptotic effect in vitro of a synthetic Siglec-8 ligand, polymeric 6'-sulfated sialyl Lewis x.

High molecular weight blood group A trisaccharide-polyacrylamide glycoconjugates as synthetic blood group A antigens for anti-A antibody removal devices.

Carbamate-linked lactose: design of clusters and evidence for selectivity to block binding of human lectins to (neo)glycoproteins with increasing degree of branching and to tumor cells.

Biotinylated multivalent glycoconjugates for surface coating.

Extensive mammalian ancestry of pandemic (H1N1) 2009 virus.

NKp46 O-glycan sequences that are involved in the interaction with hemagglutinin type 1 of influenza virus.

Distribution and function of macrophage galactose-type C-type lectin 2 (MGL2/CD301b): efficient uptake and presentation of glycosylated antigens by dendritic cells.

Adaptation of pandemic H1N1 influenza viruses in mice.

Specific antibody filter (SAF) binding capacity enhancement to remove anti-A antibodies.

Molecular adaptation of an H7N3 wild duck influenza virus following experimental multiple passages in quail and turkey.

Does pandemic A/H1N1 virus have the potential to become more pathogenic?

Serum antiglycan antibody detection of nonmucinous ovarian cancers by using a printed glycan array.

Fluorescein and radiolabeled Function-Spacer-Lipid constructs allow for simple in vitro and in vivo bioimaging of enveloped virions.

Comparison of printed glycan array, suspension array and ELISA in the detection of human anti-glycan antibodies.

Immobilization of polyacrylamide-based glycoconjugates on solid phase in immunosorbent assays.

Processing and analysis of serum antibody binding signals from Printed Glycan Arrays for diagnostic and prognostic applications.

Analysis of Tn-antigenicity with a panel of new IgM and IgG1 monoclonal antibodies raised against leukemic cells.

Hemocompatibility of liposomes loaded with lipophilic prodrugs of methotrexate and melphalan in the lipid bilayer.

Block synthesis of A tetrasaccharides (types 1, 3, and 4) related to the human ABO blood group system.